(FM) Inmunología
Departamento académico
Ángel Fernando
Panizo Santos
Investigador hasta 2010
Publicaciones en las que colabora con Ángel Fernando Panizo Santos (7)
2020
-
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression
British Journal of Haematology, Vol. 189, Núm. 6, pp. 1064-1073
2017
-
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study
European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43
2016
-
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity
Immunologic Research, Vol. 64, Núm. 2, pp. 548-557
2009
-
Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array
British Journal of Cancer, Vol. 101, Núm. 11, pp. 1876-1883
2004
-
Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis
Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761
2003
-
Adult stem cells for myocardial repair
BASIC AND APPLIED MYOLOGY, Vol. 13, Núm. 1, pp. 15 - 22
2000
-
Clinico-pathologic, immunohistochemical, and TUNEL study in early cardiac allograft failure
Cardiovascular Pathology, Vol. 9, Núm. 3, pp. 153-159